Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Alternative complement pathway (AP) plays an important role in the development of sepsis, which is life threatening. Deficiency of
factor H
-related protein 1 (FHR-1), which is a regulator of AP, has been considered as a susceptible factor for atypical hemolytic uremic syndrome (aHUS) and other types of nephropathy when an inducer such as infection exists. However, the underlying mechanism of the disease development is largely unknown. There is no report on
CFHR1
gene knockout in any animal infection model and its function
in vivo
is still unclear. Here, a
Cfhr1
knockout mouse was generated for investigating AP in sepsis and sepsis-induced acute kidney injury (AKI). We found that murine FHR-1 homolog (FHR-E) deficiency enhanced
lipopolysaccharide
(
LPS
)-induced AP activation both
in vitro
and
in vivo
and that
Cfhr1
knockout mice exhibited more severe sepsis and AKI in response to
LPS
challenge. These results indicated that FHR-E deficiency promoted
LPS
-induced sepsis and AKI through AP over-activation, providing a mouse model for studying AP regulation and sepsis. This study revealed the function of FHR-E
in vivo
, which may further provide hints to the pathogenesis of FHR-1 deficiency-related diseases by enhancing
LPS
-induced AP activation.
...
PMID:Deficiency of Mouse FHR-1 Homolog, FHR-E, Accelerates Sepsis, and Acute Kidney Injury Through Enhancing the LPS-Induced Alternative Complement Pathway. 3263 36
<< Previous
1
2
3